Skip to main content

NHS Digital Data Sharing Remote Audit: University College London

This report records the key findings of a remote data sharing audit of the University College London in September 2022.

Audit summary

Purpose

This report records the key findings of a remote data sharing audit of the University College London (UCL) where the interviews were conducted between 22 and 27 September 2022. It provides an evaluation of how UCL conforms to the requirements of both:

  • the data sharing framework contract (DSFC) CON-321538-B5D8B-v2.02
  • the data sharing agreement (DSA) DARS-NIC-381078-Y9C5K-v7.2

This DSA covers the provision of the following datasets:

Dataset Classification of data Dataset period
Electronic Prescribing and Medicines Administration (EPMA) data in Secondary Care for COVID-19 Anonymised/Pseudonymised, Non-sensitive Latest available
National Institute for Cardiovascular Outcomes Research (NICOR) Myocardial Ischaemia National Audit Project v10.3.2 Anonymised/Pseudonymised, Non-sensitive Latest available
NICOR Heart Failure V5.0 Anonymised/Pseudonymised, Non-sensitive Latest available
NICOR National Audit of Percutaneous Coronary Interventions (NAPCI) V5.6.6 Anonymised/Pseudonymised, Non-sensitive Latest available
COVID-19 ICNARC Case Mix Programme for Adult Critical Care Anonymised/Pseudonymised, Non-sensitive Latest available
TRE Secondary Care Data Anonymised/Pseudonymised, Non-sensitive Latest available
Uncurated Low Latency Hospital Data Sets – Critical Care Anonymised/Pseudonymised, Non-sensitive Latest available
Civil Registration - Deaths Anonymised/Pseudonymised, Non-sensitive Latest available
COVID-19 Hospitalization in England Surveillance System Anonymised/Pseudonymised, Non-sensitive Latest available
GPES Data for Pandemic Planning and Research (COVID-19) Anonymised/Pseudonymised, Non-sensitive Latest available
Medicines dispensed in Primary Care (NHSBSA data) Anonymised/Pseudonymised, Non-sensitive Latest available
Sentinel Stroke National Audit Programme (SSNAP) Anonymised/Pseudonymised, Non-sensitive Latest available
Uncurated Low Latency Hospital Data Sets - Admitted Patient Care Anonymised/Pseudonymised, Non-sensitive Latest available
Hospital Episode Statistics (HES) Admitted Patient Care Anonymised/Pseudonymised, Non-sensitive 1989/90 - 2023/24_M05
HES Critical Care Anonymised/Pseudonymised, Non-sensitive 2013/14 - 2023/24_M05
HES Outpatients Anonymised/Pseudonymised, Non-sensitive 2019/20 - 2023/24_M05
HES Accident and Emergency Anonymised/Pseudonymised, Non-sensitive 2007/08 – 2019/20
COVID-19 Second Generation Surveillance System Anonymised/Pseudonymised, Non-sensitive Latest available
Covid-19 UK Nonhospital Antigen Testing Results (Pillar 2) Anonymised/Pseudonymised, Non-sensitive Latest available
Covid-19 UK Nonhospital Antibody Testing Results (Pillar 3) Anonymised/Pseudonymised, Non-sensitive Latest available
COVID-19 Vaccination Status Anonymised/Pseudonymised, Non-sensitive Latest available
COVID-19 Vaccination Adverse Reactions Anonymised/Pseudonymised, Non-sensitive Latest available
Improving Access to Psychological Therapies Data Set Anonymised/Pseudonymised, Non-sensitive 2012/13 – 2022/23

 

Within the DSA, UCL is one of several joint Controllers. UCL is, however, Controller for the study audited.

CVD-COVID-UK, co-ordinated by the British Heart Foundation (BHF) Data Science Centre (DSC), is one of the NIHR-BHF Cardiovascular Partnership’s National Flagship Projects. CVD-COVID-UK aims to understand the relationship between COVID-19 and cardiovascular diseases such as heart attack, heart failure, stroke, and blood clots in the lungs through analyses of de-identified, pseudonymised, linked, nationally collated healthcare data sources in trusted research environments (TREs) across the four nations of the UK.

Building on CVD-COVID-UK, the BHF DSC has broadened the scope of the programme to all COVID-related research (currently using data in NHS Digital’s TRE for England only). This is known as COVID-IMPACT and it will help to support research projects from the wider community, including for the Data & Connectivity National Core Study.

Through this DSA, researchers from the various joint Controllers can seek to undertake COVID-19 related analyses. The particular study for this audit was Study CCU038, being conducted by UCL.

The interviews during the audit were conducted through video conferencing.

This is an exception report based on the criteria expressed in the NHS Digital Data Sharing Audit Guide version 1.

Audit Type and Scope

Audit type Focused
A focused audit was carried out due to the research utilising NHS Digital’s TRE.
Scope areas

Access Control
Data Use and Benefits
Operational Management and Control

Restrictions

This audit did not look at the process by which individual studies are assessed and managed by the BHF.
No outputs from the study have yet been produced

Overall Risk Statement

Based on evidence presented during the audit and the type of data being shared the following risk has been assigned from the options of Critical - High - Medium - Low.

Current risk statement: Low

This risk represents a deviation from the terms and conditions of the contractual documents, signed by both parties. In deriving this risk, the Audit Team will consider compliance, duty of care, confidentiality and integrity, as appropriate.

Data Recipient’s Acceptance Statement

UCL has reviewed this report and confirmed that it is accurate.

Data Recipient’s Action Plan

UCL will establish a corrective action plan to address each finding shown in the findings table below. NHS Digital will validate this plan and the resultant actions at a post audit review with UCL to confirm the findings have been satisfactorily addressed. The post audit review will also consider the outstanding evidence at which point the Audit Team may raise further findings.


Findings

The following table identifies the 1 agreement nonconformity, 1 opportunity for improvement and 1 point for follow-up raised as part of the audit.

Ref Finding Link to area Clause Designation
1 The named researcher accessing the TRE for the selected study was not a substantive employee of UCL. Use and Benefits

DSA, Annex A, Clause 5a

Agreement  nonconformity
2 The DSA, along with future versions, should be made available within the documentation set maintained on the BHF research platform for the researchers, so users are aware of their obligations and responsibilities. Operational Management   Opportunity for improvement
3 At the post audit review, the Audit Team will review the published deliverable(s) from the study. Use and Benefits

 

Follow-up

Use of data

UCL confirmed that the datasets provided in the TRE were only being processed and used for the purposes defined in the DSA.

Good Practice 

During the audit, the Audit Team noted the following area of good practice:

  • overall, the CVD-COVID-UK / COVID-IMPACT studies are contributing to health and social care
  • documentation from completed studies - including protocols, code and outputs - are made available in the public domain.

Disclaimer

The audit was based upon a sample of the data recipient’s activities, as observed by the Audit Team. The findings detailed in this audit report may not include all possible nonconformities which may exist. In addition, as the audit interviews were conducted through a video conference platform, certain controls that would normally be assessed whilst onsite could not be witnessed.

NHS Digital has prepared this audit report for its own purposes. As a result, NHS Digital does not assume any liability to any person or organisation for any loss or damage suffered or costs incurred by it arising out of, or in connection with, this report, however such loss or damage is caused. NHS Digital does not assume liability for any loss occasioned to any person or organisation acting or refraining from acting as a result of any information contained in this report.

Last edited: 23 November 2022 9:27 am